147 related articles for article (PubMed ID: 28464497)
1. Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.
Green WR; Chokshi R; Jabbour SK; DeLaney TF; Mahmoud O
Asia Pac J Clin Oncol; 2018 Feb; 14(1):101-113. PubMed ID: 28464497
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapies utilization pattern and survival outcomes in high-grade head and neck soft tissue sarcoma; a population based study.
Mahmoud O; Beck R; Kalyoussef E; Chan Park R; Baredes S; Kim S; Samuels MA
Oral Oncol; 2017 Mar; 66():28-37. PubMed ID: 28249645
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
4. Overall survival advantage of chemotherapy and radiotherapy in the perioperative management of large extremity and trunk soft tissue sarcoma; a large database analysis.
Mahmoud O; Tunceroglu A; Chokshi R; Benevenia J; Beebe K; Patterson F; DeLaney TF
Radiother Oncol; 2017 Aug; 124(2):277-284. PubMed ID: 28778347
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
[TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
Movva S; von Mehren M; Ross EA; Handorf E
J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
[TBL] [Abstract][Full Text] [Related]
8. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
Collier CD; Kim CY; Liu RW; Getty PJ
Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
[TBL] [Abstract][Full Text] [Related]
9. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
Stone BV; Tallman JE; Moses KA
J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
[TBL] [Abstract][Full Text] [Related]
10. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
11. Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection.
Schreiber D; Rineer J; Katsoulakis E; Sroufe RL; Lange CS; Nwokedi E; Schwartz D; Choi K; Rotman M
Am J Clin Oncol; 2012 Feb; 35(1):13-7. PubMed ID: 21278563
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
[TBL] [Abstract][Full Text] [Related]
13. A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients.
Greto D; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Teriaca A; Muntoni C; Delli Paoli C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):301-308. PubMed ID: 30209796
[TBL] [Abstract][Full Text] [Related]
14. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma.
Yuen NK; Li CS; Monjazeb AM; Borys D; Bold RJ; Canter RJ
J Surg Res; 2015 Dec; 199(2):494-504. PubMed ID: 26163324
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment.
Stojadinovic A; Hoos A; Karpoff HM; Leung DH; Antonescu CR; Brennan MF; Lewis JJ
Arch Surg; 2001 Jan; 136(1):70-9. PubMed ID: 11146782
[TBL] [Abstract][Full Text] [Related]
16. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
17. Assessment of multimodality therapy use for extremity sarcoma in the United States.
Sherman KL; Wayne JD; Chung J; Agulnik M; Attar S; Hayes JP; Laskin WB; Peabody TD; Bentrem DJ; Pollock RE; Bilimoria KY
J Surg Oncol; 2014 Apr; 109(5):395-404. PubMed ID: 24375444
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
[TBL] [Abstract][Full Text] [Related]
20. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Davis EJ; Chugh R; Zhao L; Lucas DR; Biermann JS; Zalupski MM; Feng M; Wong SL; Jacobson J; Zyczynski L; Reinke D; Metko G; Baker LH; Schuetze SM
Eur J Cancer; 2015 Sep; 51(13):1794-802. PubMed ID: 26066736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
